Current Rheumatology Reports

, Volume 10, Issue 2, pp 142–146

Consensus procedures and their role in pediatric rheumatology

  • Nicolino Ruperto
  • Silvia Meiorin
  • Silvia Mirela Iusan
  • Angelo Ravelli
  • Angela Pistorio
  • Alberto Martini
Article

Abstract

The Delphi Technique and Nominal Group Technique are two well-recognized consensus-formation methodologies specifically designed to combine judgments from a group of experts. The Delphi Technique utilizes a series of well-defined questionnaire-based surveys, whereas Nominal Group Technique is a structured face-to-face meeting designed to facilitate consensus. Consensus-formation techniques require that each step build on the results of the previous steps. In this review, we describe these techniques, how they work, and their practical application in pediatric rheumatology, where they have been widely used to develop the outcome measures of several chronic rheumatic diseases, including juvenile idiopathic arthritis, rheumatoid arthritis, systemic lupus erythematosus, and idiopathic inflammatory myopathies, as well as the classification criteria for juvenile systemic sclerosis and juvenile vasculitides.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References and Recommended Reading

  1. 1.
    Delbecq AL, Van de Ven AH, Gustafson DH: Group Techniques for Program Planning: A Guide to Nominal Group and Delphi Processes, edn 1. Glenview, IL: Scott, Foresman and Company; 1975.Google Scholar
  2. 2.
    Dalkey NC: Delphi. Santa Monica, CA: Rand Corporation; 1967.Google Scholar
  3. 3.
    Helmer O: Analysis of the Future: the Delphi Method. Santa Monica, CA: Rand Corporation; 1967.Google Scholar
  4. 4.
    Giannini EH, Ruperto N, Ravelli A, et al.: Preliminary definition of improvement in juvenile arthritis. Arthritis Rheum 1997, 40:1202–1209.PubMedGoogle Scholar
  5. 5.
    Ruperto N, Ravelli A, Murray KJ, et al.: Preliminary core sets of measures for disease activity and damage assessment in juvenile systemic lupus erythematosus and juvenile dermatomyositis. Rheumatology (Oxford) 2003, 42:1452–1459.CrossRefGoogle Scholar
  6. 6.
    Jones J, Hunter D: Consensus methods for medical and health services research. BMJ 1995, 311:376–380.PubMedGoogle Scholar
  7. 7.
    van Teijlingen E, Pitchforth E, Bishop C, Russell E: Delphi method and nominal group technique in family planning and reproductive health research. J Fam Plann Reprod Health Care 2006, 32:249–252.PubMedCrossRefGoogle Scholar
  8. 8.
    Keeney S, Hasson F, McKenna HP: A critical review of the Delphi technique as a research methodology for nursing. Int J Nurs Stud 2001, 38:195–200.PubMedCrossRefGoogle Scholar
  9. 9.
    McKee M, Priest P, Ginzler M, Black N: How representative are members of expert panels? Qual Assur Health Care 1991, 3:89–94.PubMedGoogle Scholar
  10. 10.
    Lovell DJ, Giannini EH, Reiff A, et al.: Etanercept in children with polyarticular juvenile rheumatoid arthritis. Pediatric Rheumatology Collaborative Study Group. N Engl J Med 2000, 342:763–769.PubMedCrossRefGoogle Scholar
  11. 11.
    Ruperto N, Lovell DJ, Cuttica R, et al.: A randomized, placebo-controlled trial of infliximab plus methotrexate for the treatment of polyarticular-course juvenile rheumatoid arthritis. Arthritis Rheum 2007, 56:3096–3106.PubMedCrossRefGoogle Scholar
  12. 12.
    Ruperto N, Lovell DJ, Prieur AM, et al.: Efficacy and safety of abatacept in children and adolescents with active juvenile idiopathic arthritis (JIA). Ann Rheum Dis 2006, 65(Suppl 11):248.Google Scholar
  13. 13.
    Ruperto N, Lovell DJ, Goodman S, et al.: 48-week data from the study of adalimumab in children with juvenile rheumatoid arthritis (JRA). Ann Rheum Dis 2006, 65(Suppl 11):56.Google Scholar
  14. 14.
    Wallace CA, Ruperto N, Giannini E, et al.: Preliminary criteria for clinical remission for select categories of juvenile idiopathic arthritis. J Rheumatol 2004, 31:2290–2294.PubMedGoogle Scholar
  15. 15.
    Wallace CA, Huang B, Bandeira M, et al.: Patterns of clinical remission in select categories of juvenile idiopathic arthritis. Arthritis Rheum 2005, 52:3554–3562.PubMedCrossRefGoogle Scholar
  16. 16.
    Ruperto N, Martini A: International research networks in pediatric rheumatology: the PRINTO perspective. Curr Opin Rheumatol 2004, 16:566–570.PubMedCrossRefGoogle Scholar
  17. 17.
    Giannini EH, Brewer EJ, Kuzmina N, et al.: Methotrexate in resistant juvenile rheumatoid arthritis. Results of the U.S.A.-U.S.S.R. double-blind, placebo-controlled trial. The Pediatric Rheumatology Collaborative Study Group and the Cooperative Children’s Study Group. N Engl J Med 1992, 326:1043–1049.PubMedGoogle Scholar
  18. 18.
    Martini A, Ruperto N, Lovell DJ, et al.: An international consensus conference to define core sets of outcome measures for juvenile systemic lupus erythematosus and juvenile dermatomyositis. Proceedings of the Conference, March 31–April 3, 2001. Pavia, Italy: Paediatric Rheumatology International Trials Organization (PRINTO); 2001.Google Scholar
  19. 19.
    Ruperto N, Ravelli A, Cuttica R, et al.: The Pediatric Rheumatology International Trials Organization criteria for the evaluation of response to therapy in juvenile systemic lupus erythematosus: prospective validation of the disease activity core set. Arthritis Rheum 2005, 52:2854–2864.PubMedCrossRefGoogle Scholar
  20. 20.
    Ruperto N, Ravelli A, Pistorio A, et al.: The provisional Paediatric Rheumatology International Trials Organisation/American College of Rheumatology/European League Against Rheumatism Disease activity core set for the evaluation of response to therapy in juvenile dermatomyositis: a prospective validation study. Arthritis Rheum 2007, 59:4–13.CrossRefGoogle Scholar
  21. 21.
    Ruperto N, Ravelli A, Oliveira S, et al.: The Pediatric Rheumatology International Trials Organization/American College of Rheumatology provisional criteria for the evaluation of response to therapy in juvenile systemic lupus erythematosus: prospective validation of the definition of improvement. Arthritis Rheum 2006, 55:355–363.PubMedCrossRefGoogle Scholar
  22. 22.
    Rider LG, Giannini EH, Brunner HI, et al.: International consensus on preliminary definitions of improvement in adult and juvenile myositis. Arthritis Rheum 2004, 50:2281–2290.PubMedCrossRefGoogle Scholar
  23. 23.
    Oddis CV, Rider LG, Reed AM, et al.: International consensus guidelines for trials of therapies in the idiopathic inflammatory myopathies. Arthritis Rheum 2005, 52:2607–2615.PubMedCrossRefGoogle Scholar
  24. 24.
    Ramanan AV, Schneider R, Batthish M, et al.: Developing a disease activity tool for systemic-onset juvenile idiopathic arthritis by international consensus using the Delphi approach. Rheumatology (Oxford) 2005, 44:1574–1578.CrossRefGoogle Scholar
  25. 25.
    Zulian F, Woo P, Athreya BH, et al.: The Pediatric Rheumatology European Society/American College of Rheumatology/European League against Rheumatism provisional classification criteria for juvenile systemic sclerosis. Arthritis Rheum 2007, 57:203–212.PubMedCrossRefGoogle Scholar
  26. 26.
    Ozen S, Ruperto N, Dillon MJ, et al.: EULAR/PReS endorsed consensus criteria for the classification of childhood vasculitides. Ann Rheum Dis 2006, 65:936–941.PubMedCrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media, LLC 2008

Authors and Affiliations

  • Nicolino Ruperto
    • 1
  • Silvia Meiorin
  • Silvia Mirela Iusan
  • Angelo Ravelli
  • Angela Pistorio
  • Alberto Martini
  1. 1.IRCCS G. Gaslini, Pediatria II-PRINTOUniversity of GenoaGenovaItaly

Personalised recommendations